Abstract #294: Potential Relevance of Changes in Hematocrit to Changes in Lipid Parameters with Empagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM)

Endocrine Practice(2016)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要